7.3 Corresponding Responsibility, Drug Diversion & Red Flags

7.3 Corresponding Responsibility, Drug Diversion & Red Flags

Quick Answer: Under 21 CFR § 1306.04 and Tenn. Comp. R. & Regs. 1140-03-.01, a pharmacist shares a legal corresponding responsibility with the prescriber to ensure that every controlled substance prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. An order lacking legitimate medical purpose is legally void, and a pharmacist who fills it with "willful blindness" to obvious red flags is guilty of unlawful drug distribution. Pharmacists must identify objective and behavioral red flags (e.g., the Pharmacy Triangle, the Holy Trinity, high MME, cash-only payments, doctor shopping), investigate and resolve them, contemporaneously document the resolution, or exercise their affirmative duty to refuse to fill.

---

1. Legal Doctrine of Corresponding Responsibility

The doctrine of Corresponding Responsibility is the cornerstone of controlled substance dispensing jurisprudence. Codified in federal regulation at 21 CFR § 1306.04(a) and incorporated into Tennessee jurisprudence through T.C.A. § 53-11-308 and Tenn. Comp. R. & Regs. 1140-03-.01, the doctrine establishes an interlocking standard of professional accountability:

[!IMPORTANT] 21 CFR § 1306.04(a) Statutory Language:
"A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice. The responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription. An order purporting to be a prescription issued not in the usual course of professional treatment or in legitimate and authorized research is not a prescription within the meaning and intent of section 309 of the Act (21 U.S.C. 829) and the person knowingly filling such a purported prescription, as well as the person issuing it, shall be subject to the penalties provided for violations of the provisions of law relating to controlled substances."

The Two-Pronged Legal Test

For any controlled substance prescription to be legally valid in Tennessee, it must satisfy both prongs of the statutory standard:

1. Legitimate Medical Purpose: The medication must be clinically indicated to treat a bona fide disease, injury, or medical condition based on recognized clinical standards.
2. Usual Course of Professional Practice: The prescriber must be acting within the accepted boundaries of their licensed medical specialty, having conducted an in-person physical examination, taken a thorough medical history, established a treatment plan, and monitored therapeutic outcomes.

If a purported prescription fails either prong, it is legally void—it ceases to be a prescription under the law, functioning instead as an illegal order for contraband narcotics.

---

2. Willful Blindness & The Legal Standard of "Knowledge"

A common defense raised by pharmacists accused of dispensing diverted controlled substances is: "The prescriber wrote it, and the prescriber has a DEA license; I didn't know the patient was diverting."

Federal and Tennessee courts have roundly and universally rejected this defense under the doctrine of Conscious Avoidance or Willful Blindness (see United States v. Lawson, United States v. Moore, and DEA administrative decisions such as Holiday CVS, L.L.C.):

┌─────────────────────────────────────────────────────────────────────────────┐
│                      THE "WILLFUL BLINDNESS" DOCTRINE                       │
├─────────────────────────────────────────────────────────────────────────────┤
│ In a regulatory or criminal proceeding:                                     │
│ • "Knowledge" is established if a pharmacist was presented with RED FLAGS    │
│   (obvious warning signs of non-medical use or diversion) and DELIBERATELY   │
│   CHOSE NOT TO INQUIRE or resolved them with superficial, sham inquiries.   │
│ • A pharmacist cannot insulate themselves from liability by acting as a      │
│   passive "order-filler" or robotic automaton.                              │
│ • Closing one's eyes to red flags satisfies the legal definition of          │
│   KNOWINGLY dispensing an invalid controlled substance order.               │
└─────────────────────────────────────────────────────────────────────────────┘

---

3. Objective Red Flags & The Pharmacy Triangle

Red flags are observable clinical, geographical, or transactional characteristics that strongly suggest a prescription may not be legitimate. The DEA and the Tennessee Board of Pharmacy divide these into objective red flags and behavioral red flags.

The "Pharmacy Triangle" (Geographic Anomalies)

One of the most heavily scrutinized objective red flags is geographic distance. Legitimate medical care is typically local. A red flag arises when an illogical distance separates the three vertices of the dispensing triangle:

1. Patient's Residence
2. Prescriber's Office Location
3. Dispensing Pharmacy Location

                  [Prescriber Office]
                  (e.g., Chattanooga, TN)
                         /        \
                        /          \
             120 Miles /            \ 95 Miles
                      /              \
                     /                \
    [Patient Residence] ------------ [Dispensing Pharmacy]
    (e.g., Crossville, TN)  85 Miles   (e.g., Knoxville, TN)

[!CAUTION] If a patient bypasses dozens of open retail pharmacies in their home community to travel 100+ miles to visit a cash-only clinic, and then drives another 50 miles to fill the prescription at a specific independent pharmacy, this extreme geographic anomaly is an unresolved red flag. The pharmacist cannot dispense without an extraordinary, documented clinical justification (e.g., highly specialized tertiary academic oncology clinic).

Pattern Prescribing

Pattern prescribing occurs when a prescriber generates identical prescriptions for multiple, unrelated patients who arrive in groups or in close succession:

• Identical drug cocktails: Every patient receives Oxycodone 30 mg #120 plus Alprazolam 2 mg #90.
• Uniform maximum dosages without individualized clinical titration.
• Prescriptions written for cash-paying individuals of similar age groups presenting from the same distant locality.

---

4. Dangerous Drug Combinations: The "Holy Trinity" & High MME Thresholds

The "Holy Trinity" (Lethal Drug Cocktail)

The most infamous and lethal drug diversion cocktail encountered in community pharmacy practice is known on the street and in regulatory enforcement as the "Holy Trinity":

┌─────────────────────────────────────────────────────────────────────────────┐
│                     THE NOTORIOUS "HOLY TRINITY" COCKTAIL                   │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Drug Class & Representative│ Pharmacological & Clinical Impact               │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ 1. Potent Opioid         │ Binds mu-opioid receptors; provides central      │
│    (Oxycodone 30 mg /    │ analgesia and intense euphoria. High overdose    │
│    Hydrocodone 10 mg)    │ respiratory depression risk.                     │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ 2. Benzodiazepine        │ Positive GABAA allosteric modulator; enhances    │
│    (Alprazolam 2 mg /    │ opioid-induced sedation and euphoria; blunts     │
│    Clonazepam 2 mg)      │ hypercapnic respiratory drive.                   │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ 3. Muscle Relaxant       │ Centrally acting muscle relaxant metabolized to  │
│    (Carisoprodol [Soma]  │ meprobamate (a Schedule IV barbiturate-like drug);│
│    350 mg)               │ potentiates profound central nervous depression. │
└──────────────────────────┴──────────────────────────────────────────────────┘

[!WARNING] The concurrent prescribing of an opioid, benzodiazepine, and carisoprodol possesses virtually zero recognized medical utility in modern outpatient practice. Clinical guidelines from the CDC, FDA, and Tennessee Department of Health state that this combination synergistically suppresses respiratory drive and is a primary driver of fatal overdoses. Dispensing the Holy Trinity without extensive, specialized documentation is treated by the Board of Pharmacy as prima facie evidence of reckless dispensing.

High Morphine Milligram Equivalents (MME)

Under the Tennessee Together opioid initiatives and Board rules, daily Morphine Milligram Equivalents (MME) must be calculated prior to dispensing:

• MME > 50 / day: Increases overdose risk two-fold; warrants caution and clinical assessment.
• MME > 90 / day: High-risk dosage threshold under CDC and Tennessee guidelines; requires explicit justification, pain management agreement, and strong consideration of co-prescribing naloxone.
• MME ≥ 120 / day: Extreme risk threshold. Prescriptions exceeding 120 MME per day without an active cancer or palliative diagnosis represent a glaring clinical red flag requiring exhaustive inquiry.

---

5. Behavioral Red Flags & Patient Presentation Indicators

Behavioral red flags reflect patient conduct, presentation, and manipulation tactics observed at the pharmacy counter:

┌─────────────────────────────────────────────────────────────────────────────┐
│                     COMMUNITY PHARMACY RED FLAGS MATRIX                     │
├──────────────────────┬──────────────────────────────────────────────────────┤
│ Red Flag Category    │ Specific Indicators & Warning Signs                  │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Cash Transactions    │ • Patient insists on paying cash for expensive brand │
│                      │   narcotics (e.g., OxyContin, Subutex, Opana) despite│
│                      │   having active commercial insurance or TennCare.    │
│                      │ • Refusal to bill insurance to bypass prior          │
│                      │   authorization or avoid CSMD automated tracking.    │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Refill & Timing      │ • Repeated requests for early refills (e.g., 5-10    │
│ Anomalies            │   days early each month).                            │
│                      │ • Chronic, recurring excuses: "lost bottle,"         │
│                      │   "stolen purse," "dropped down sink," "spilled."    │
│                      │ • Attempting to fill a prescription days before an   │
│                      │   authorized "do not fill before" date.              │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Doctor & Pharmacy    │ • CSMD profile reveals concurrent controlled scripts │
│ Shopping             │   from 3+ unrelated prescribers within 60 days.      │
│                      │ • Multiple pharmacies utilized across county lines.  │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Physical Document    │ • Forged, altered, or photocopied prescription forms.│
│ Tampering            │ • Differing ink colors, overwritten numbers (e.g., 10│
│                      │   altered to 40, or 30 altered to 90).               │
│                      │ • Missing Tennessee tamper-resistant security traits │
│                      │   or invalid/expired DEA numbers.                    │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Patient Demeanor     │ • Nervous, agitated, or evasive behavior.            │
│ & Conduct            │ • Aggressive posturing, demanding immediate fill.    │
│                      │ • Arriving in groups with coordinated cash pools.    │
│                      │ • Extreme focus on specific pill brands or markings. │
└──────────────────────┴──────────────────────────────────────────────────────┘

---

6. Operational Due Diligence: Prospective Clinical Evaluation & Prescriber Inquiry

When a pharmacist detects one or more red flags, what is the mandatory operational protocol? A pharmacist cannot simply dispense the drug and document "called doctor, OK to fill." That is legally deficient sham verification.

Step-by-Step Due Diligence Workflow

┌─────────────────────────────────────────────────────────────────────────────┐
│                     PHARMACIST RED FLAG RESOLUTION WORKFLOW                 │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. IDENTIFY RED FLAGS:                                                      │
│    Review prescription elements, patient history, and CSMD report.         │
│                                                                             │
│ 2. CONDUCT PROSPECTIVE CLINICAL INTERVIEW:                                  │
│    Question the patient regarding their medical condition, pain history,    │
│    functional goals, and reason for selecting this pharmacy/prescriber.     │
│                                                                             │
│ 3. CONTACT PRESCRIBER DIRECTLY:                                             │
│    Call the prescriber using an INDEPENDENTLY VERIFIED telephone number     │
│    (from the state medical board database or verified clinic directory,     │
│    NEVER the unverified phone number printed on a suspicious paper form!).  │
│                                                                             │
│ 4. SUBSTANTIVE CLINICAL INQUIRY:                                            │
│    Inquire about: patient diagnosis, ICD-10 code, treatment plan, non-opioid│
│    therapies attempted, pain management contracts, and toxicology screens.  │
│                                                                             │
│ 5. EVALUATE TOTALITY OF CIRCUMSTANCES:                                      │
│    Determine whether the clinical explanations completely resolve and       │
│    dispel every identified red flag.                                        │
│                                                                             │
│ 6. CONTEMPORANEOUS IMMUTABLE DOCUMENTATION:                                 │
│    If resolved: Record detailed notes in the pharmacy dispensing software    │
│    (date, time, prescriber contact, clinical rationale, resolution steps).  │
│                                                                             │
│ 7. MANDATORY REFUSAL TO FILL:                                               │
│    If red flags CANNOT be dispelled, or if prescriber cannot be reached or  │
│    provides evasive answers: REFUSE TO FILL.                                │
└─────────────────────────────────────────────────────────────────────────────┘

---

7. Safe Refusal to Fill & Legal Protections

Under Tennessee law and professional ethical canons, a pharmacist has an unqualified affirmative right and legal obligation to refuse to dispense any prescription that:

1. Violates federal or state law;
2. Is not issued for a legitimate medical purpose;
3. Would compromise patient safety or induce an overdose; or
4. Presents unresolved red flags suggesting diversion.

Immunity and Protection

Pharmacists who refuse to fill in good faith based on professional judgment, suspected diversion, or safety concerns are protected under Tennessee jurisprudence from wrongful refusal or discrimination claims. A prescriber cannot compel a pharmacist to dispense, and pharmacy corporate employers cannot penalize a pharmacist for exercising their statutory corresponding responsibility to protect public health.

Reporting to Authorities

If a pharmacist discovers an actively forged, counterfeit, or stolen prescription blank, the pharmacist should:

• Retain the forged document (or a clear photocopy if the presenter flees);
• Contact local law enforcement (police or sheriff's department);
• Notify the Tennessee Board of Pharmacy and the DEA Diversion Control Division; and
• Alert nearby pharmacies in the community to prevent the diverter from successfully filling elsewhere.

---

8. Practical Exam Scenarios

Scenario 1: The Out-of-Town Holy Trinity Cash Fill

Case: A 29-year-old patient residing in Clarksville presents three paper prescriptions to a community pharmacy in Murfreesboro (100 miles away) written by a pain clinic practitioner in Chattanooga (120 miles away). The prescriptions are for Oxycodone 30 mg #120, Alprazolam 2 mg #90, and Carisoprodol 350 mg #60. The patient insists on paying $850 in cash despite having an active TennCare card. What is the pharmacist's legal obligation? Legal Analysis: This presentation exhibits multiple glaring red flags: (1) Extreme geographic anomaly (the Pharmacy Triangle: Clarksville ↔ Chattanooga ↔ Murfreesboro); (2) The classic "Holy Trinity" cocktail; (3) Maximum dosage Schedule II and IV drugs; and (4) Cash payment on high-dollar narcotics while holding TennCare. Under 21 CFR § 1306.04 and Tenn. Comp. R. & Regs. 1140-03-.01, these red flags cannot be resolved by a simple routine confirmation. Unless extraordinary, verifiable oncologic or specialized clinical documentation is provided directly by the clinic, the pharmacist has an affirmative duty to refuse to fill. Dispensing this order constitutes willful blindness and unlawful drug distribution.

Scenario 2: CSMD Reveals Doctor Shopping

Case: A patient presents a prescription for Hydrocodone/Acetaminophen 10/325 mg #60 written by an emergency medicine physician. The pharmacist checks the CSMD pursuant to T.C.A. § 53-10-310 and discovers that within the past 21 days, the patient filled three identical 5-day supplies of hydrocodone prescribed by three different urgent care clinics in surrounding counties, paying cash at three different retail pharmacies. Legal Analysis: The CSMD report demonstrates classic, textbook doctor shopping and pharmacy shopping. The patient is concealing prior concurrent controlled substance therapies. Under T.C.A. § 53-11-308 and Board Rule 1140-03-.01, the pharmacist must not dispense the medication, must notify the emergency room physician of the multiple concurrent fills, document the refusal in the pharmacy software, and report the doctor shopping to the CSMD Committee or local authorities.

Scenario 3: Legitimate High MME Dose in Palliative Care

Case: A 62-year-old patient with end-stage pancreatic cancer, receiving home palliative care, presents a prescription for Morphine Sulfate ER 60 mg tablets (1 tablet every 12 hours) and Morphine Sulfate IR 15 mg tablets (1 tablet every 4 hours as needed for breakthrough pain). The daily MME is approximately 150 MME/day. The patient lives 3 miles from the pharmacy and prescriber. Legal Analysis: While the total daily MME exceeds the 120 MME threshold, this clinical scenario does not constitute an illicit red flag. The patient has a documented terminal malignancy, is receiving legitimate palliative care (statutorily exempt under T.C.A. § 53-10-310(b)), exhibits no geographic anomalies, has no history of doctor shopping on the CSMD, and utilizes standard insurance billing. After performing prospective clinical evaluation and confirming hospice/palliative documentation, the pharmacist may lawfully dispense the medication with documented clinical rationale.